Jack Meehan; Analyst; Nephron Research Erin Wright; Analyst; Morgan Stanley ...

Q4 2024 Earnings Call Transcript January 30, 2025 Quest Diagnostics Incorporated beats earnings expectations. Reported EPS is ...

During Q4 2024, global stocks were pressured by investor concerns about economic growth and persistent inflation in some regions & despite potential for further interest rate cuts in 2025.

Elevance Health’s share price has started 2025 off nicely, up over 9% on the year. It provided a total return of -21% in 2024. Shares gained moderately after the company reported its Q4 earnings ...

The healthcare industry is undergoing rapid transformation, driven by advancements in technology, artificial intelligence, ...

According to LCH Investments, over 200 hedge funds are Tiger Cubs, funds started by former employees of Tiger Management, the ...

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target ...

In a report released today, Stephen Baxter from Wells Fargo maintained a Buy rating on Elevance Health (ELV – Research Report), with a price ...

Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $492.5, with a ...